Stem Cell Therapy Success Rates by Condition (2026)

Direct answer: Stem-cell therapy has no single success rate. The strongest, proven results are in haematopoietic transplantation for blood and immune disorders (established, often curative). For most other conditions it remains investigational — “success” usually means slowed progression or symptom improvement in a subset of patients, reported in early-phase trials rather than large randomised studies. Below is the honest, per-condition picture; for context on how to read trial figures, see how to read stem-cell success rates.

Reported outcomes by condition

Condition	Area	What the evidence reports
自闭症谱系障碍	Neurodevelopmental	What the evidence reports →
糖尿病（1型和2型）	Metabolic	What the evidence reports →
多发性硬化症	Autoimmune / Neuro	What the evidence reports →
帕金森病	Neurodegenerative	What the evidence reports →
阿尔茨海默病	Neurodegenerative	What the evidence reports →
脑性瘫痪	Neurodevelopmental	What the evidence reports →
脊髓性肌萎缩症	Genetic / Neuromuscular	What the evidence reports →
肌肉营养不良	Genetic / Neuromuscular	What the evidence reports →
类风湿关节炎	Autoimmune	What the evidence reports →
肝硬化	Organ / Fibrotic	What the evidence reports →
贫血	Haematologic	What the evidence reports →
动脉高血压	Cardio-metabolic	What the evidence reports →
勃起功能障碍	Men's health	What the evidence reports →
男性不育症	Men's health	What the evidence reports →
原发性免疫缺陷	Immunologic	What the evidence reports →
美容与抗衰老	Aesthetic / Longevity	What the evidence reports →
发育认知延迟	Neurodevelopmental	What the evidence reports →
膝关节骨关节炎	Orthopaedic	What the evidence reports →
背痛与椎间盘退行性变	Orthopaedic / Spine	What the evidence reports →
周围神经病变	Neurological	What the evidence reports →
中风恢复	Neurological	What the evidence reports →
慢性阻塞性肺病和肺部疾病	Respiratory	What the evidence reports →
克罗恩病和炎性肠病	Autoimmune / GI	What the evidence reports →
狼疮（SLE）	Autoimmune	What the evidence reports →
慢性肾脏病	Organ	What the evidence reports →
脱发和毛发修复	Aesthetic	What the evidence reports →
长期COVID	Post-viral / Immune	What the evidence reports →
脊髓损伤	Neurological	What the evidence reports →
心脏衰竭和心脏修复	Cardiac	What the evidence reports →
ALS（肌萎缩侧索硬化症）	Neurodegenerative	What the evidence reports →
银屑病	Autoimmune / Skin	What the evidence reports →
骨质疏松症和骨骼健康	Orthopaedic / Metabolic	What the evidence reports →
肌腱损伤和运动损伤	Orthopaedic	What the evidence reports →
慢性伤口和溃疡	Tissue repair	What the evidence reports →
黄斑变性和视力	Ophthalmic	What the evidence reports →
纤维肌痛症和慢性疲劳综合征	Chronic pain / Neuro	What the evidence reports →
髋关节骨关节炎	Orthopaedic	What the evidence reports →
硬皮病（系统性硬化症）	Autoimmune	What the evidence reports →
卵巢功能不全	Women's health	What the evidence reports →
更年期和激素健康	Women's health	What the evidence reports →
复杂区域疼痛综合征	Neurological / pain	What the evidence reports →
溃疡性结肠炎	Autoimmune / GI	What the evidence reports →

Figures on each linked page come from registered clinical trials and published clinic series, not promotional claims. Most uses are investigational; check approval status before booking.

Compare cost & regulation: 2026年成本指数 · best countries by condition · cost calculator.

Stem-cell success rates — common questions

What is the success rate of stem cell therapy?

There is no single success rate. Outcomes depend on the condition, the cell type, the study design and how “success” is defined (symptom relief, biomarker change, or cure). Most regenerative therapies are still investigational, so reported figures come from early-phase trials and clinic series rather than large randomised trials. The strongest evidence is in haematopoietic transplantation for blood and immune disorders; for most other conditions, benefit means slowed progression or symptom improvement in a subset of patients, not a cure.

Why isn’t there one success-rate number for stem cell therapy?

Because “stem cell therapy” covers many cell types and dozens of conditions at very different evidence levels. A figure quoted for knee osteoarthritis says nothing about multiple sclerosis. Honest reporting is condition-by-condition, with the trial stage and what was actually measured — which is how we present it on each condition page.

Which conditions have the strongest evidence?

Haematopoietic stem-cell transplantation is established and curative for selected blood and immune disorders. MSC-based therapy has approved use for perianal fistulae in Crohn’s disease. Orthopaedic uses (knee, joints) and autoimmune conditions show the most promising early-trial data among investigational uses. Always check the approval status and trial stage for your specific condition.

Stem cell therapy success rates by condition (2026)

Reported outcomes by condition

Stem-cell success rates — common questions

What is the success rate of stem cell therapy?

Why isn’t there one success-rate number for stem cell therapy?

Which conditions have the strongest evidence?

欧洲品质的细胞疗法，没有欧洲的价格。